HomeInfraStocks in news: IndiGo, Mphasis, IRB Infra, Raymond, BPCL

Stocks in news: IndiGo, Mphasis, IRB Infra, Raymond, BPCL

Date:

Related stories

Severe delays hit London Underground line ahead Tube strike

Noora MykkanenPublished Nov 5, 2024, 6:26am|Updated Nov 5, 2024,...

NEWS: GPs Urge Government to Block Tax Hike | Practice Business

As reported by BBC News, GPs warn that rising...

UK resumes tech-focused trade talks with South Korea

Tuesday 05 November 2024 6:00 am  |  Updated:  Monday 04 November 2024...

UK retail sales growth slumps as shoppers wait for Black Friday deals

Growth in UK retail sales slumped in October, according...
spot_imgspot_img

After a hectic five days, domestic markets started the new week on a subdued note on Monday and ended slightly lower. In today’s trade, shares of IndiGo, Mphasis, IRB Infra, Raymond, BPCL among others will be in focus due to various news developments.

IndiGo

InterGlobe Enterprises, one of the promoters of IndiGo, is planning to sell around 2% stake in the company through a block deal, according to reports.

Mphasis
Global private equity and investment firm Blackstone offloaded a partial stake in IT services company Mphasis through bulk deals on Monday.

IRB Infrastructure
Cintra is likely to sell around 5% stake of IRB Infra through block deals on Monday, according to reports.RVNL
RVNL emerged as the lowest bidder for a Central Railway project worth Rs 138.45 crore. In another development, Siemens-RVNL consortium has received letter of acceptance (LoA) for Bangalore Metro Rail Corp project worth Rs 394 crore.

Raymond
Raymond arm Raymond Realty secured redevelopment residential project in Bandra East, Mumbai. This project is estimated to generate a revenue of more than Rs 2000 crore.

BPCL
State-run Bharat Petroleum Corporation (BPCL) plans to set up a new 12 million metric tonnes per annum (MMTPA) refinery in the country, ET reported.

JSW Steel
JSW Steel reported consolidated crude steel production at 20.98 lakh tonnes for the month of May, which is 4% lower year-on-year.

Lupin
Lupin said it is recalling over 51,000 bottles of a generic antibiotic medication in the US market due to a defective container.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img